# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 08-14-2024 | 06-30-2024 | 10-Q | |
2 | 05-15-2024 | 03-31-2024 | 10-Q | |
3 | 03-29-2024 | 12-31-2023 | 10-K | |
4 | 12-11-2023 | 09-30-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Case Studies Highlight Potential of Elevai Exosome Technology in Melasma Care When Used with Laser Therapy. Early Results Sh...
Elevai Labs, Inc. (NASDAQ:ELAB) ("Elevai" or the "Company"), a pioneering force in medical aesthetics, announce...